Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

被引：0
|
作者：
Ji Young Yun
Han-Joon Kim
Jee-Young Lee
Young Eun Kim
Ji Seon Kim
Jong-Min Kim
Beom S Jeon
机构：
[1] Ewha Womans University Mokdong Hospital,Department of Neurology
[2] Seoul National University,Department of Neurology, College of Medicine
[3] Seoul National University Hospital,Movement Disorder Center
[4] Seoul National University-Seoul Metropolitan Government Boramae Medical Center,Department of Neurology
[5] Seoul National University Bundang Hospital,Department of Neurology
[6] Chungbuk National University Hospital,Department of Neurology
来源：
BMC Neurology | / 13卷
关键词：
Parkinson’s disease; Motor control; Movement disorders; Dopamine agonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 41 条
  • [31] Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain
    Madeo, Graziella
    Schirinzi, Tommaso
    Natoli, Silvia
    Pierantozzi, Mariangela
    Stefani, Alessandro
    Dauri, Mario
    Pisani, Antonio
    JOURNAL OF NEUROLOGY, 2015, 262 (09) : 2164 - 2170
  • [32] Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain
    Graziella Madeo
    Tommaso Schirinzi
    Silvia Natoli
    Mariangela Pierantozzi
    Alessandro Stefani
    Mario Dauri
    Antonio Pisani
    Journal of Neurology, 2015, 262 : 2164 - 2170
  • [33] Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: Results of two randomized studies in patients with Parkinson's disease
    Tompson, Debra J.
    Vearer, Deborah
    CLINICAL THERAPEUTICS, 2007, 29 (12) : 2654 - 2666
  • [34] Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia
    Robert A. Hauser
    Shyamal H. Mehta
    Daniel Kremens
    Dustin Chernick
    Andrea E. Formella
    Neurology and Therapy, 2021, 10 : 739 - 751
  • [35] Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson’s disease: a meta-analysis
    De-Qi Jiang
    Ming-Xing Li
    Li-Lin Jiang
    Xiao-Bai Chen
    Xing-Wen Zhou
    Aging Clinical and Experimental Research, 2020, 32 : 769 - 779
  • [36] Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson's disease: a meta-analysis
    Jiang, De-Qi
    Li, Ming-Xing
    Jiang, Li-Lin
    Chen, Xiao-Bai
    Zhou, Xing-Wen
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 32 (05) : 769 - 779
  • [37] The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: A multicenter, double-blind, randomized, placebo-controlled study
    Zhang, Zhenxin
    Wang, Jian
    Zhang, Xiaoying
    Chen, Shengdi
    Wang, Zhenfu
    Zhang, Baorong
    Liu, Chunfeng
    Qu, Qiumin
    Cheng, Yan
    Li, Jie
    Cao, Haijun
    Cai, Meng
    Zhu, Rongxuan
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (11) : 1022 - 1026
  • [38] Comparison of pramipexole and levodopa/benserazide combination therapy versus levodopa/benserazide monotherapy in the treatment of Parkinson’s disease: a systematic review and meta-analysis
    De-Qi Jiang
    Qing-Min Zang
    Li-Lin Jiang
    Yan Wang
    Ming-Xing Li
    Jing-Yi Qiao
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 1893 - 1905
  • [39] Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson's Disease: Clinical Trial Post Hoc Analyses
    Pahwa, Rajesh
    Aldred, Jason
    Gupta, Niodita
    Terasawa, Emi
    Garcia-Horton, Viviana
    Steffen, David R.
    Kandukuri, Prasanna L.
    Chaudhari, Vivek S.
    Jalundhwala, Yash J.
    Bao, Yanjun
    Kukreja, Pavnit
    Isaacson, Stuart H.
    NEUROLOGY AND THERAPY, 2022, 11 (02) : 711 - 723
  • [40] Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses
    Rajesh Pahwa
    Jason Aldred
    Niodita Gupta
    Emi Terasawa
    Viviana Garcia-Horton
    David R. Steffen
    Prasanna L. Kandukuri
    Vivek S. Chaudhari
    Yash J. Jalundhwala
    Yanjun Bao
    Pavnit Kukreja
    Stuart H. Isaacson
    Neurology and Therapy, 2022, 11 : 711 - 723
12345